I sincerely hope this isn't a pump and dump from UBS and it is a genuine accumulation of shares by certain parties.
The only thing that will drive the SP is earnings growth, if Axiron continues to erode away at the market share of Androgel then there's no doubt the SP will continue to grow past $1.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.002(11.1%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.6¢ | $39.34K | 2.216M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 971151 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 565000 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ACR (ASX) Chart |